Manufacturers can enhance the batch release process in drug development by integrating three key digital fundamentals. Learn how to streamline operations efficiently.

The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...

Background The elimination of HBV covalently closed circular DNA (cccDNA) remains a critical hurdle for chronic hepatitis B (CHB) management. Objective In this investigation, we examined the efficacy ...

US - Nonconsensual Third-Party Releases Are Alive And Well In Chapter 15 Despite Purdue. Legal News and Analysis - USA - ...